Filing Details

Accession Number:
0001019056-13-000815
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-27 17:09:27
Reporting Period:
2013-06-27
Filing Date:
2013-06-27
Accepted Time:
2013-06-27 17:09:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
792641 Bio Reference Laboratories Inc BRLI Services-Medical Laboratories (8071) 222405059
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189451 Sam Singer 481 Edward H. Ross Drive
Elmwood Park NJ 07407
Svp, Cfo And Cao Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-06-27 4,000 $28.95 11,132 No 4 S Indirect By Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Family Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,000 Indirect By Family Trust
Common Stock 15,000 Indirect By Children
Common Stock 1,000 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in more than one transaction at price ranging from $28.90 to $29.00, inclusive. The reporting person undertakes to provide to Bio-Reference Laboratories, Inc., any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. Owned by trusts for the benefit of Mr. Singer and his family members, of which Nancy Kelly-Singer, Mr. Singer's wife, and Mr. Singer are co-trustees.
  3. Owned by one of Mr. Singer's children who shares the same home as Mr. Singer. Mr. Singer disclaims beneficial ownership of these securities, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.